کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2660678 | 1140366 | 2009 | 7 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Bioidentical Hormones, Compounding, and Evidence-Based Medicine: What Women's Health Practitioners Need to Know
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
پزشکی و دندانپزشکی (عمومی)
پیش نمایش صفحه اول مقاله

چکیده انگلیسی
For many years, hormone therapy (HT), administered as estrogen alone (for hysterectomized women) or combined estrogen/progestin (for nonhysterectomized women), has been an effective treatment for menopausal symptoms and osteoporosis prevention. Questions regarding the benefit–risk profile of HT have prompted some women to seek alternative therapies. Compounded bioidentical HT has been promoted as a potentially safer option than conventional HT; however, there are a lack of sufficient data from well-designed comparative trials to support the safety or efficacy of this approach. Compounded bioidentical hormone formulations may be associated with additional risks for variability in quality, purity, and batch-to-batch consistency.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: The Journal for Nurse Practitioners - Volume 5, Issue 6, June 2009, Pages 421–427
Journal: The Journal for Nurse Practitioners - Volume 5, Issue 6, June 2009, Pages 421–427
نویسندگان
Penelope M. Bosarge, Sarah Freeman,